P190B RhoGAP Regulates Chromosome Segregation in Cancer Cells.

Cancers
Melissa HwangTracy Vargo-Gogola

Abstract

Rho GTPases are overexpressed and hyperactivated in many cancers, including breast cancer. Rho proteins, as well as their regulators and effectors, have been implicated in mitosis, and their altered expression promotes mitotic defects and aneuploidy. Previously, we demonstrated that p190B Rho GTPase activating protein (RhoGAP) deficiency inhibits ErbB2-induced mammary tumor formation in mice. Here we describe a novel role for p190B as a regulator of mitosis. We found that p190B localized to centrosomes during interphase and mitosis, and that it is differentially phosphorylated during mitosis. Knockdown of p190B expression in MCF-7 and Hela cells increased the incidence of aberrant microtubule-kinetochore attachments at metaphase, lagging chromosomes at anaphase, and micronucleation, all of which are indicative of aneuploidy. Cell cycle analysis of p190B deficient MCF-7 cells revealed a significant increase in apoptotic cells with a concomitant decrease in cells in G1 and S phase, suggesting that p190B deficient cells die at the G1 to S transition. Chemical inhibition of the Rac GTPase during mitosis reduced the incidence of lagging chromosomes in p190B knockdown cells to levels detected in control cells, suggesting that aberran...Continue Reading

References

Dec 29, 1995·The Journal of Biological Chemistry·P D BurbeloY Yamada
Feb 7, 1998·Science·A Hall
May 18, 1999·International Journal of Cancer. Journal International Du Cancer·G FritzB Kaina
Jan 23, 2003·The Journal of Cell Biology·Amy Shaub Maddox, Keith Burridge
Mar 15, 2003·Molecular Endocrinology·Geetika ChakravartyJeffrey M Rosen
Nov 12, 2003·The Journal of Cell Biology·Ling SuSarah J Parsons
Jan 14, 2004·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Amy M FowlerElaine T Alarid
Apr 16, 2004·Nature·Shingo YasudaShuh Narumiya
Jun 1, 2004·Molecular and Cellular Biology·Maria I KontaridisAnton M Bennett
Oct 12, 2004·Annual Review of Cell and Developmental Biology·Yixian Zheng
Oct 10, 2006·Developmental Neuroscience·Stephen F MathesonJeffrey Settleman
Nov 3, 2007·Cancer Research·Beth A A Weaver, Don W Cleveland
Jul 2, 2008·Journal of Cancer Research and Clinical Oncology·K StrumaneJ G Collard
Jul 22, 2008·Cell Cycle·Masahito MikawaSarah J Parsons
Aug 2, 2008·Proceedings of the National Academy of Sciences of the United States of America·Noah DephoureSteven P Gygi
Oct 25, 2008·Current Biology : CB·Rodrigo I BustosSteen H Hansen
Jan 21, 2009·Cancer Metastasis Reviews·Alan Hall
Mar 4, 2009·Experimental Cell Research·Ling SuSarah J Parsons
Jun 24, 2009·Nature Reviews. Molecular Cell Biology·Andrew J Holland, Don W Cleveland
Aug 26, 2009·Breast Cancer Research : BCR·Brandy M Heckman-StoddardJeffrey M Rosen
Mar 26, 2010·Current Biology : CB·Sarah L ThompsonDuane A Compton
Jun 11, 2010·The Journal of Biological Chemistry·Sergio A Sánchez ManchinellySarah J Parsons
Jul 14, 2010·Current Biology : CB·María Dolores Vázquez-Novelle, Mark Petronczki
Sep 24, 2010·Breast Cancer Research : BCR·Peter R McHenryTracy Vargo-Gogola
Mar 31, 2011·Journal of the National Cancer Institute·Ines BaroneSuzanne A W Fuqua
Sep 29, 2011·Developmental Biology·B M Heckman-StoddardJ M Rosen
Jan 10, 2012·Current Opinion in Cell Biology·Christopher B O'ConnellBruce F McEwen

❮ Previous
Next ❯

Methods Mentioned

BETA
GTPases
GTPase
nucleotide exchange
immunoprecipitation
transfection
flow cytometry
confocal microscopy
Assay

Software Mentioned

CREST
ImageJ
Zen
Zen imaging

Related Concepts

Related Feeds

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis